(GLP-1 receptor agonist + GIP receptor agonist)

Tirzepatide is a research peptide being studied for its possible effects on appetite, blood sugar, insulin signaling, and body weight. Researchers are especially interested in it because it works through two different signaling pathways at the same time.

GLP-1 signal – researchers study this pathway for how it may increase fullness, reduce appetite, and slow digestion.
GIP signal – researchers study how this pathway may affect insulin response, blood sugar, and the way the body handles nutrients.

Together, these two signals are being studied for their combined effects on appetite, weight management, blood sugar, and metabolic function.

Benefits:
Appetite control
Reduced cravings
Weight and fat loss
Blood sugar control
Body composition
Insulin sensitivity

Tirzepatide may be of interest in research focused on appetite, weight management, blood sugar, insulin sensitivity, metabolic function, and body composition. It may be especially relevant when several of these areas are part of the same research focus.

Research Use Only. Products are intended for laboratory and research purposes only and are not intended for human consumption or clinical use.